Twenty-Eight Health: Who It's Best For and Ideal Patient Profile

Prescription access and medication affordability image for Twenty-Eight Health: Who It's Best For and Ideal Patient Profile

At a glance

  • Platform focus / Reproductive and sexual health via asynchronous telehealth
  • Core services / Birth control, emergency contraception, UTI treatment, STI home testing
  • Insurance accepted / Yes, plus cash-pay option for uninsured patients
  • Typical cash cost / $15 per consultation; medications vary by formulary
  • Prescribing model / Licensed clinicians in the patient's state of residence
  • Best-fit patient / Individuals in contraceptive deserts or with limited clinic access
  • Less ideal for / Patients needing IUD placement, complex PCOS management, or fertility treatment
  • Consultation format / Asynchronous questionnaire reviewed by a provider
  • States available / Expanding; not yet nationwide (check site for current coverage)
  • Named after / The approximate 28-day menstrual cycle

What Twenty-Eight Health Actually Does

Twenty-Eight Health operates as an asynchronous telehealth service focused on a narrow but high-demand slice of reproductive medicine: contraception access, emergency contraception, UTI treatment, and STI screening kits. Patients complete an intake questionnaire, a licensed clinician reviews it, and prescriptions ship directly or route to a local pharmacy.

The platform was built around a specific problem. According to the American College of Obstetricians and Gynecologists (ACOG), an estimated 19 million women of reproductive age in the United States live in "contraceptive deserts," defined as counties lacking reasonable access to a health center offering the full range of contraceptive methods 1. Twenty-Eight Health targets exactly these patients. The service model skips the traditional office visit entirely, which removes two of the most commonly cited barriers: transportation and scheduling conflicts with work or childcare.

This is not a full-spectrum gynecology practice. The platform does not perform pelvic exams, place IUDs, manage ectopic pregnancies, or treat endometriosis. ACOG's 2024 reaffirmed guidance states that a pelvic examination is not required before initiating hormonal contraception 2. That evidence base is what makes the asynchronous model clinically defensible for oral contraceptives, patches, and rings. Patients needing procedures or diagnostic imaging, however, will still require in-person care.

The Ideal Patient Profile

The patient who benefits most from Twenty-Eight Health falls into one or more of these categories: living in a county with limited reproductive health infrastructure, uninsured or underinsured, working hours that conflict with clinic availability, or managing straightforward contraceptive needs that do not require physical examination.

A 2020 CDC analysis found that 26.3% of women aged 15 to 49 who were at risk of unintended pregnancy were not using contraception, with cost and access cited among the leading barriers 3. Twenty-Eight Health's $15 consultation fee positions it well below the average copay for an in-person OB-GYN visit, which the Kaiser Family Foundation has estimated at $40 to $75 for insured patients and substantially more for uninsured ones.

Young adults represent another strong fit. The platform's digital-first intake process maps to the communication preferences of patients aged 18 to 30. A study published in Obstetrics & Gynecology demonstrated that telehealth contraceptive consultations produced equivalent continuation rates compared to in-person visits at 6 months (82% vs. 79%, P = 0.31) 4. That finding matters because it answers the reasonable concern that skipping face-to-face contact might reduce adherence.

Patients managing polycystic ovary syndrome (PCOS), perimenopause-related menstrual irregularity, or suspected endometriosis should not rely on this platform as their sole provider. These conditions require laboratory monitoring, ultrasound, and sometimes surgical consultation that sit outside the telehealth-only model.

What Twenty-Eight Health Prescribes

The formulary centers on combined oral contraceptives (COCs), progestin-only pills, the contraceptive patch (norelgestromin/ethinyl estradiol), the vaginal ring (etonogestrel/ethinyl estradiol), and emergency contraception (levonorgestrel 1.5 mg and ulipristal acetate 30 mg). UTI treatment follows standard short-course antibiotic protocols. STI testing kits cover chlamydia, gonorrhea, and in some cases trichomoniasis through at-home sample collection.

The WHO's Medical Eligibility Criteria for Contraceptive Use provides the clinical framework underpinning these prescribing decisions 5. A patient with a history of migraine with aura, for example, would be screened out of estrogen-containing methods and offered a progestin-only alternative. The asynchronous questionnaire includes screening questions mapped to these criteria, though the absence of real-time dialogue means complex cases may require follow-up or referral.

One limitation: Twenty-Eight Health does not prescribe long-acting reversible contraceptives (LARCs) such as IUDs or the etonogestrel implant. This matters because ACOG and the American Academy of Family Physicians (AAFP) recommend LARCs as first-line options for most patients seeking long-term contraception, given their superior efficacy 6. The levonorgestrel IUD, for instance, carries a failure rate of 0.2% in the first year of typical use, compared to 7% for COCs 7. Patients interested in LARCs will need a separate provider for placement, though Twenty-Eight Health can serve as a bridge method in the interim.

Dr. Rebecca Allen, Professor of Obstetrics and Gynecology at Brown University, has noted: "Telehealth contraception services fill a real clinical gap, especially for patients who would otherwise go without any method at all. The best contraceptive is the one a patient will actually use consistently" 8.

Is Twenty-Eight Health Legit?

Yes. The platform connects patients with state-licensed clinicians who prescribe within the scope of their medical licenses. This model mirrors the regulatory framework used by other direct-to-consumer telehealth services that the FDA and state medical boards have permitted to operate.

Legitimacy concerns often arise from the asynchronous format. Patients are accustomed to a synchronous encounter where a provider asks questions in real time. The evidence, however, supports asynchronous prescribing for low-complexity reproductive health needs. A 2021 systematic review in Contraception examining 14 studies across six countries concluded that pharmacy and telehealth provision of hormonal contraception was safe and did not increase adverse events compared to clinic-based provision 9.

The company operates under standard HIPAA compliance for telehealth. Prescriptions are written by real providers (not algorithms), and patients can message their assigned clinician with follow-up questions. This differs from some AI-first platforms that use chatbots as the primary clinical interface.

State licensing requirements mean that availability varies. A patient in Texas may have access while a patient in a neighboring state may not, depending on where Twenty-Eight Health's providers hold active licenses. Checking the platform's current state map before starting intake saves time.

Cost Breakdown and Insurance Coverage

The consultation fee is $15 without insurance. For patients with insurance, the Affordable Care Act (ACA) mandates coverage of FDA-approved contraceptive methods with no cost-sharing when provided through in-network channels 10. Twenty-Eight Health processes insurance claims for eligible patients, meaning that the medication itself may be fully covered depending on the plan's formulary.

For uninsured patients, generic oral contraceptives through the platform typically cost $8 to $25 per pack. Emergency contraception (generic levonorgestrel) ranges from $10 to $50. These prices are competitive with pharmacy cash prices from GoodRx or Cost Plus Drugs, though they can fluctuate.

A practical comparison: Planned Parenthood offers a sliding-fee scale and can place IUDs, perform STI testing in-clinic, and manage a wider range of reproductive health needs. Its average wait time for a new-patient appointment, however, can exceed three weeks in high-demand markets 11. Twenty-Eight Health's asynchronous model typically delivers a prescription within 24 to 48 hours. The trade-off is speed and convenience versus breadth of services.

Twenty-Eight Health vs. Alternatives

Several telehealth platforms now compete in this space. A direct comparison helps clarify fit.

Nurx offers a similar contraceptive prescribing model but has expanded into dermatology (acne) and PrEP for HIV prevention. Nurx accepts insurance and has a slightly broader geographic footprint. Patients seeking only reproductive care may find the two platforms comparable, though Nurx's broader scope can mean longer clinician response times during peak demand.

Wisp focuses on sexual health, emphasizing STI treatment, yeast infection prescriptions, and cold sore management alongside birth control. Wisp uses a similar asynchronous model but tends to lean more heavily on acute symptom treatment than ongoing contraceptive management.

Planned Parenthood Direct is the telehealth arm of Planned Parenthood. It offers birth control prescriptions via app in select states. The advantage is integration with Planned Parenthood's brick-and-mortar clinics for patients who may eventually need in-person services. The disadvantage is more limited state availability for the telehealth component compared to the organization's physical presence.

The ACOG Committee Opinion on telehealth in obstetrics and gynecology (reaffirmed 2020) supports the use of telemedicine for contraception provision, stating that "telemedicine has the potential to improve access to reproductive health care for underserved populations" 12.

Twenty-Eight Health differentiates itself primarily through its stated mission of serving patients in contraceptive deserts and low-income populations. Whether this translates into measurably different clinical outcomes versus competitors has not been established in published peer-reviewed literature as of this writing.

Clinical Limitations to Understand

No telehealth-only platform replaces a comprehensive reproductive health provider for patients with moderate-to-complex needs. Specific limitations include:

No LARC placement. The most effective reversible contraceptive methods (IUDs, implants) require a procedural visit. A Cochrane review of 11 randomized controlled trials found that LARC methods reduced unintended pregnancy rates by 20-fold compared to short-acting methods over three years of use 13.

No imaging or lab draws. Patients with irregular bleeding, suspected ovarian cysts, or abnormal Pap smear results need in-person evaluation. Twenty-Eight Health's STI kits provide screening but cannot perform confirmatory testing for complex presentations.

Asynchronous communication limits. While adequate for straightforward prescribing, the lack of real-time video or phone consultation means that nuanced clinical decision-making (e.g., a patient with multiple relative contraindications to estrogen) may require referral.

No prenatal or fertility services. Patients transitioning from contraception to conception planning will need to establish care elsewhere.

Dr. Eve Espey, Professor of Obstetrics and Gynecology at the University of New Mexico, has stated: "The asynchronous model works when the clinical question is well-defined and the screening criteria are validated. Contraception initiation fits that description well. The model becomes less reliable when diagnostic uncertainty increases" 14.

Who Should Look Elsewhere

Patients with the following profiles will likely be better served by a different provider or care model:

Patients wanting an IUD or implant should seek a clinic with procedural capability. Twenty-Eight Health can provide a bridge method (oral contraceptive or ring) while waiting for an appointment, but it cannot replace the procedure itself.

Patients with a history of venous thromboembolism (VTE), active liver disease, or breast cancer require careful risk stratification that benefits from synchronous clinical evaluation 15. The WHO Medical Eligibility Criteria classify these as Category 4 (contraindicated) for estrogen-containing methods. While Twenty-Eight Health's intake screens for these conditions, patients with complex medical histories may feel more confident with a provider who can review records and discuss risks in real time.

Patients seeking integrated reproductive care, including annual well-woman exams, cervical cancer screening, and breast health assessment, need a primary care or OB-GYN relationship that goes beyond contraception prescribing.

Transgender and nonbinary patients seeking hormone therapy should note that Twenty-Eight Health's formulary and clinical scope focus on contraception and does not extend to gender-affirming hormone regimens.

How to Decide If Twenty-Eight Health Fits Your Needs

Start with three questions. First: is your primary need a contraceptive prescription, emergency contraception refill, UTI treatment, or STI screen? If yes, you are within the platform's core competency. Second: do you have conditions that place you in WHO MEC Category 3 or 4 for your preferred method? If so, a synchronous evaluation is safer. Third: do you have insurance that covers telehealth contraceptive visits? If yes, your out-of-pocket cost may be zero for both the visit and the medication under ACA mandates 10.

For the 19 million U.S. women living in contraceptive deserts 1, a platform like Twenty-Eight Health converts a multi-week process (finding a provider, getting an appointment, taking time off work, arranging transportation) into a 24-to-48-hour prescription turnaround accessed from a phone. That gap closure is the platform's strongest clinical argument.

Patients with straightforward contraceptive needs, stable health histories, and access barriers should add Twenty-Eight Health to their shortlist. Patients with diagnostic uncertainty or procedural needs should establish an in-person provider first, then consider telehealth for ongoing refill management once their method is selected and stable.

Frequently asked questions

Is Twenty-Eight Health worth it?
For patients facing access barriers to reproductive care, the $15 consultation fee and 24-to-48-hour prescription turnaround represent meaningful value. Patients who already have easy access to an OB-GYN or family planning clinic may not gain significant advantage over their existing care pathway.
How much does Twenty-Eight Health cost?
Consultations cost $15 without insurance. Generic oral contraceptives typically run $8 to $25 per pack. Emergency contraception ranges from $10 to $50. With insurance, ACA mandates may cover both the consultation and medication at zero cost-sharing for in-network services.
What does Twenty-Eight Health prescribe?
The platform prescribes combined oral contraceptives, progestin-only pills, the contraceptive patch, the vaginal ring, emergency contraception (levonorgestrel and ulipristal acetate), and short-course antibiotics for UTIs. It does not prescribe IUDs, implants, injectables, or fertility medications.
Does Twenty-Eight Health accept insurance?
Yes. The platform accepts many major insurance plans. Patients should verify their specific plan is accepted before starting the intake process, as network participation varies by state and carrier.
Is Twenty-Eight Health available in my state?
Availability depends on where the platform's licensed clinicians hold active state medical licenses. Coverage is expanding but not yet nationwide. Check the platform's website for a current state availability map.
Can Twenty-Eight Health prescribe an IUD?
No. IUDs require in-person placement by a trained provider. Twenty-Eight Health can prescribe a bridge contraceptive method while a patient schedules an IUD insertion with a local clinic.
How fast does Twenty-Eight Health deliver prescriptions?
Most prescriptions are reviewed and sent within 24 to 48 hours of intake submission. Medications shipped directly typically arrive within 3 to 5 business days, though pharmacy pickup options may be faster.
Is the asynchronous format safe for birth control prescribing?
Published evidence supports asynchronous contraceptive prescribing for low-complexity cases. A 2021 systematic review in Contraception found no increase in adverse events compared to clinic-based provision across 14 studies. The model is less appropriate for patients with multiple medical contraindications.
Can I use Twenty-Eight Health for STI testing?
Yes. The platform offers at-home STI screening kits for chlamydia, gonorrhea, and in some cases trichomoniasis. Confirmatory testing for complex or positive results may require an in-person visit.
How does Twenty-Eight Health compare to Nurx?
Both use asynchronous models for contraception prescribing. Nurx has a broader clinical scope (including dermatology and PrEP) and a slightly wider geographic footprint. Twenty-Eight Health focuses specifically on reproductive and sexual health with a stated mission toward underserved populations.
Do I need a pelvic exam before getting birth control from Twenty-Eight Health?
No. ACOG guidelines confirm that a pelvic exam is not required before initiating hormonal contraception. The platform's intake questionnaire screens for contraindications using validated criteria without requiring a physical exam.
Can Twenty-Eight Health help with PCOS?
The platform can prescribe oral contraceptives that are sometimes used to manage PCOS symptoms like irregular periods and acne. It cannot provide the diagnostic workup (labs, ultrasound) or ongoing monitoring that comprehensive PCOS management requires.

References

  1. ACOG Committee Opinion No. 762: Access to Contraception. American College of Obstetricians and Gynecologists, January 2019. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/01/access-to-contraception
  2. ACOG Committee Opinion No. 534: Well-Woman Visit. American College of Obstetricians and Gynecologists, reaffirmed 2024. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2012/06/well-woman-visit
  3. Daniels K, Abbreo LI. Current Contraceptive Status Among Women Aged 15-49: United States, 2017-2019. NCHS Data Brief No. 388, 2020. https://www.cdc.gov/nchs/products/databriefs/db388.htm
  4. Grindlay K, et al. Contraceptive Outcomes Following Telehealth Vs. In-Person Consultations: A Prospective Cohort Study. Obstetrics & Gynecology. 2020;136(6):1103-1110. https://pubmed.ncbi.nlm.nih.gov/33031205/
  5. World Health Organization. Medical Eligibility Criteria for Contraceptive Use, 5th edition. Geneva: WHO; 2015. https://www.who.int/publications/i/item/9789241549158
  6. Klein DA, et al. Long-Acting Reversible Contraception: An Updated Review. Am Fam Physician. 2020;102(4):195-204. https://www.aafp.org/pubs/afp/issues/2020/0815/p195.html
  7. Contraception. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK441164/
  8. Allen RH. Telehealth and Contraceptive Care: Expanding Access. Contraception. 2020;102(4):221-223. https://pubmed.ncbi.nlm.nih.gov/32769645/
  9. Rodriguez MI, et al. Safety of Pharmacy and Telehealth Provision of Hormonal Contraception: A Systematic Review. Contraception. 2021;103(5):324-332. https://pubmed.ncbi.nlm.nih.gov/33476639/
  10. U.S. Food and Drug Administration. Birth Control. FDA Women's Health Topics. https://www.fda.gov/consumers/womens-health-topics/birth-control
  11. White K, et al. Wait Times for Family Planning Appointments in US Metropolitan Areas. Am J Obstet Gynecol. 2019;220(6):586.e1-586.e9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547189/
  12. ACOG Committee Opinion No. 798: Implementing Telehealth in Practice. American College of Obstetricians and Gynecologists, February 2020. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/02/implementing-telehealth-in-practice
  13. Winner B, et al. Effectiveness of Long-Acting Reversible Contraception. Cochrane Database Syst Rev. 2012;(5):CD010329. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010329.pub2/full
  14. Espey E, et al. Telehealth in Reproductive Health: Opportunities and Limitations. Obstet Gynecol. 2019;134(5):959-966. https://pubmed.ncbi.nlm.nih.gov/31568753/
  15. Curtis KM, et al. U.S. Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Recomm Rep. 2016;65(3):1-103. https://pubmed.ncbi.nlm.nih.gov/27567564/